Complex Made Simple

Medtronic survey: needles make top ten of Kuwait’s residents biggest fears list

Diabetes patients can now reduce injections directly to their skin from 120 times in a typical month, to only once every three days with Medtronic’s newly available injection aid, the i-Port Advance

Needles top the list of Kuwait residents’ biggest fears according to a recent nationwide survey where residents were asked to rank things people are commonly afraid of.

Respondents listed having injections in sixth place behind a fear of snakes, sharks, heights, public speaking and spiders.

The survey also revealed that one-third of respondents said they would rather skydive from a plane if it meant being able to avoid needles every day, with over a quarter saying they would rather handle a python. Unfortunately, while most people only have to brave the occasional needle throughout their lifetime it’s a different story for the 23% of Kuwait’s residents living with diabetes, many of whom will be faced with having to inject themselves up to four times per day.

Pediatric Endocrinologist, Dr. Fahad Al Jasser from Amiri Hospital and Dasman Diabetes Institute said the survey results were not surprising and having to self-inject every day was an ordeal for many people with diabetes.

“Taking injections before each meal can be a psychological and physical burden due to the associated pain. Missing an insulin dose should not be an option when it comes to type one patients with diabetes. Adolescents sometimes skip a dose of insulin because they can’t face another injection – and this can obviously have serious health consequences,” Dr. Fahad said.

“Using an injection aid may decrease the risk of future injection problems especially for younger patients and facilitate the use of multiple daily injections, which may contribute to a decreased risk of long-term complications. I would encourage all diabetics who face the burden of multiple daily injections to talk with their healthcare professional to seek advice on alternative solutions,” he said.

The survey was commissioned by Medtronic , the global leader in medical technology, to coincide with its newly introduced injection aid, enabling patients to reduce injections directly to their skin from 120 times in a typical month, to only once every three days.

Aljahra Hospital, Ministry of Health, Specialist Endocrinologist, Dr. Ayed El Enezy said Medtronic’s injection aid solution is the i-Port Advance, a wearable technology used by people living with diabetes on injection therapy that provides a safe, effective, and easy way for patients to administer insulin.

“i-Port, which stands for injection port is a three-day-wearable device that people with diabetes inject into instead of injecting directly into the skin,” he said. “i-Port Advance, which was released in the Kuwait in May means people with insulin-dependent diabetes may no longer have to suffer multiple skin punctures every day,” he added.

“With nearly half of all patients on daily injection therapy reporting bruising and more than one third reporting pain, the device is expected to be a game-changer in the treatment of diabetes. The i-Port will also help relieve those who experience anxiety from injecting their diabetes medications,” he concluded.

“In fact, a prospective study, which involved 100 nurses and 100 patients in a community hospital revealed that the i-Port Advance decreased anxiety of needles in patients by 100%,” he further added.

Healthcare professionals and people with diabetes interested in learning more about the i-Port Advance can visit www.medtronic-diabetes-mena.com.